miRNAs and PPAR-gamma-induced neuroprotection
miRNAs and PPAR-gamma-induced neuroprotection
批准号:
8338957
负责人:
Raghu VEMUGANTI
金额:
$18.81万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-07-01 至 2014-06-30
关键词:
AcuteAgonistBindingBinding SitesBiogenesisBioinformaticsBrainCodeComputer SimulationDataEquilibriumExperimental ModelsFunctional RNAGene ExpressionGenesGenetic TranslationGlucoseGoalsIntronsIschemiaLigandsLipidsMediatingMessenger RNAMicroRNAsPC12 CellsPPAR gammaPeroxisome Proliferator-Activated ReceptorsPeroxisome ProliferatorsPlasmidsPlayProteinsRNA Polymerase IIRattusResponse ElementsRoleSeedsStreamTestingTranscription Initiation SiteTranslationsUntranslated Regionsactivating transcription factorbaseinteinneuroprotectionpromoterprotein expressionrosiglitazonetranscription factorvector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The miRNAs are transcribed as primary miRNAs (primiRs) by RNA polymerase II from either independent miRNA genes or from the introns of protein-coding genes. The miRNA gene promoters are known to contain many transcription factor binding sites, but the role of transcription factors in miRNA biogenesis is not yet understood. We made an in silico observation that the promoters of certain miRNAs contain binding sites for the transcription factor PPAR? known as PPREs. Preliminary studies showed that several miRNAs that contain PPREs in their promoters were induced by PPAR? agonist rosiglitazone indicating that PPAR¿ might control the expression of miRNAs. In addition to targeting 3'-UTRs of mRNAs to repress translation, the miRNAs can also bind to the promoters of protein-coding genes in a sequence-specific manner. With bioinformatics, we observed binding sites for 4 miRNAs in PPAR? promoter indicating that those miRNAs might control PPAR? gene expression. Interestingly, PPAR? promoter contains binding sites for miRNAs that have PPREs in their promoters. For example, promoters of mir-329 and miR-145 showed 4 PPREs each while PPAR? promoter showed binding site for both miR-329 and miR-145. We hypothesize that PPAR? and specific miRNAs modulate each other with significant consequences in maintaining cellular equilibrium. Furthermore, some of the pleiotropic neuroprotective effects of PPAR? agonists might be due to their effect on miRNAs. Aim 1 is to test if PPAR? activation alters the expression of PPRE-containing miRNAs and to study if PPAR? down-stream miRNAs play a role in PPAR-mediated neuroprotection. Aim 2 is to test if specific miRNAs can induce PPAR? expression by promoter interaction and if that can potentiate the neuroprotection afforded by PPAR? agonists. The overall goal is to study if PPAR? is in a cyclical loop with certain miRNA and their mutual inducibility has functional significance.
PUBLIC HEALTH RELEVANCE: Transcription factors and microRNAs are master controllers of gene and protein expression. This proposal wishes to evaluate the mutual interaction and the subsequent consequences of a transcription factor known as PPAR with certain miRNAs in mediating neuroprotection after ischemia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of RNAs in post-stroke brain damage
-
批准号:10664336
-
项目类别:
-
资助金额:$61.57万
-
财政年份:2023
-
负责人:Raghu VEMUGANTI
-
依托单位:
Epitranscriptomic regulation by m6A RNA methylation after stroke
-
批准号:10604801
-
项目类别:
-
资助金额:$61.81万
-
财政年份:2023
-
负责人:Raghu VEMUGANTI
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10618195
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Raghu VEMUGANTI
-
依托单位:
miR-21 induced neuroprotection after stroke
-
批准号:10513282
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Raghu VEMUGANTI
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10373075
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:Raghu VEMUGANTI
-
依托单位:
Neuroprotection after TBI
-
批准号:10454793
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Raghu VEMUGANTI
-
依托单位:
Neuroprotection after TBI
-
批准号:10158429
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:9757829
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:10261564
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:10001037
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
DNA hydroxymethylation and post stroke brain damage
-
批准号:10462714
-
项目类别:
-
资助金额:$41.54万
-
财政年份:2018
-
负责人:Raghu VEMUGANTI
-
依托单位:
Therapeutic Targeting of an lncRNA in Experimental Stroke Using STAIR Criteria
-
批准号:9323794
-
项目类别:
-
资助金额:$42.17万
-
财政年份:2017
-
负责人:Raghu VEMUGANTI
-
依托单位:
Targeting alpha-synuclein after cerebral ischemia as a function of sex and age
-
批准号:9891108
-
项目类别:
-
资助金额:$32.91万
-
财政年份:2017
-
负责人:Raghu VEMUGANTI
-
依托单位:
Role of alpha Synuclein and microRNA 7a in post stroke brain damage
-
批准号:8924344
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Raghu VEMUGANTI
-
依托单位:
Role of alpha Synuclein and microRNA 7a in post stroke brain damage
-
批准号:9281538
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Raghu VEMUGANTI
-
依托单位:
LncRNA FosDT mediates ischemic brain damage
-
批准号:9139511
-
项目类别:
-
资助金额:$30.69万
-
财政年份:2015
-
负责人:Raghu VEMUGANTI
-
依托单位:
Combo therapy to curtail oxidative stress after TBI
-
批准号:8735202
-
项目类别:
-
资助金额:$7.45万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
Synergy of ER stress and oxidative stress after TBI
-
批准号:8598653
-
项目类别:
-
资助金额:$18.81万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
Synergy of ER stress and oxidative stress after TBI
-
批准号:8696902
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
Combo therapy to curtail oxidative stress after TBI
-
批准号:8637393
-
项目类别:
-
资助金额:$7.53万
-
财政年份:2013
-
负责人:Raghu VEMUGANTI
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: